«EarliTec Diagnostics announced it has received FDA 510(k) clearance for a device that helps clinicians identify autism spectrum disorder for children between the ages of 16 and 30 months old.»

«The tool, called EarliPoint Evaluation, uses eye-tracking technology to monitor a child’s looking behavior while they watch short videos of other children interacting with one another. The technology measures focus and responsiveness, which can be compared against age-expected metrics.» 

«»This is a significant milestone as we continue to develop innovative technologies designed to improve the lives of children and families affected by autism,» Sreeni Narayanan, EarliTec’s chief technology officer, said in a statement. «How we quantify moment-by-moment behavior of a child not only provides objective measures of each child’s strengths and weaknesses today – measures that can be universally available and accessible to all families – it provides a digital health platform that can support care in the future, so that all individuals affected by autism receive timely, individualized care.»»

Article written by Emily Olsen

Photo: Getty Images



MobiHealth News